---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006139"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T23:02:55.489703+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Amends $20M patent deal to credit R&D costs; raises $710K via stock sales

## Summary
- Amends Patent Purchase Agreement; cash payments reduced to $306K from $373K as of Dec 31, 2024.
- Issued 155,555 shares at $2.25/share for $350K to accredited investor in private placement.
- Received $210K from exercise of 140,000 warrants at $1.50/share on Feb 10.
- Received $150K from exercise of 100,000 warrants at $1.50/share on Feb 11.
- Series B Preferred converted 216 shares (stated value $237,600) into 105,600 common shares.

## SEC filing metadata
- accession: 0001493152-25-006139
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225006139/0001493152-25-006139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225006139/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006139
- JSON: https://secwatch.observer/filing/0001493152-25-006139.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.